Furthermore, MAP2K3 expression was significantly correlated with ESCC patient age and tumor differentiation, with well‐differentiated tumors displaying stronger MAP2K3 expression than poorly differentiated tumors (Table 1). The gene discussed is MAP2K3; the disease is neoplasm.